Last reviewed · How we verify

NCT03819062

Sacral Neuromodulation as Treatment for Chronic Constipation

Recruiting now NA Last updated 5 April 2022
What this trial tests

NA trial testing Low Level Laser Therapy in Chronic Constipation in 20 participants. Currently enrolling.

Timeline
8 September 2019
Primary endpoint
1 February 2025
1 February 2027

Quick facts

Lead sponsorMcMaster University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date8 September 2019
Primary completion1 February 2025
Estimated completion1 February 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

McMaster University

Who can join

Adults 6 to 70, any sex, with Chronic Constipation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to study if low level laser therapy will do more good than harm for patients with severe chronic refractory constipation. It is a proof of concept study without a placebo arm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Low Level Laser Therapy

Trials testing the same drug.

Other recruiting trials for Chronic Constipation

Currently open trials in the same condition.

Other McMaster University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing